JP7589393B2 - 滅菌処理したヘテロシクリデンアセトアミド誘導体含有懸濁液 - Google Patents

滅菌処理したヘテロシクリデンアセトアミド誘導体含有懸濁液 Download PDF

Info

Publication number
JP7589393B2
JP7589393B2 JP2024521732A JP2024521732A JP7589393B2 JP 7589393 B2 JP7589393 B2 JP 7589393B2 JP 2024521732 A JP2024521732 A JP 2024521732A JP 2024521732 A JP2024521732 A JP 2024521732A JP 7589393 B2 JP7589393 B2 JP 7589393B2
Authority
JP
Japan
Prior art keywords
aqueous suspension
acetamide
trifluoromethylchroman
tetrahydronaphthalen
ylidene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2024521732A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2024071348A5 (https=
JPWO2024071348A1 (https=
Inventor
有希 山下
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Senju Pharmaceutical Co Ltd
Mochida Pharmaceutical Co Ltd
Original Assignee
Senju Pharmaceutical Co Ltd
Mochida Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharmaceutical Co Ltd, Mochida Pharmaceutical Co Ltd filed Critical Senju Pharmaceutical Co Ltd
Publication of JPWO2024071348A1 publication Critical patent/JPWO2024071348A1/ja
Publication of JPWO2024071348A5 publication Critical patent/JPWO2024071348A5/ja
Priority to JP2024198093A priority Critical patent/JP2025024083A/ja
Application granted granted Critical
Publication of JP7589393B2 publication Critical patent/JP7589393B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2024521732A 2022-09-29 2023-09-28 滅菌処理したヘテロシクリデンアセトアミド誘導体含有懸濁液 Active JP7589393B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024198093A JP2025024083A (ja) 2022-09-29 2024-11-13 滅菌処理したヘテロシクリデンアセトアミド誘導体含有懸濁液

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2022156060 2022-09-29
JP2022156060 2022-09-29
PCT/JP2023/035547 WO2024071348A1 (ja) 2022-09-29 2023-09-28 滅菌処理したヘテロシクリデンアセトアミド誘導体含有懸濁液

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024198093A Division JP2025024083A (ja) 2022-09-29 2024-11-13 滅菌処理したヘテロシクリデンアセトアミド誘導体含有懸濁液

Publications (3)

Publication Number Publication Date
JPWO2024071348A1 JPWO2024071348A1 (https=) 2024-04-04
JPWO2024071348A5 JPWO2024071348A5 (https=) 2024-09-05
JP7589393B2 true JP7589393B2 (ja) 2024-11-25

Family

ID=90478164

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2024521732A Active JP7589393B2 (ja) 2022-09-29 2023-09-28 滅菌処理したヘテロシクリデンアセトアミド誘導体含有懸濁液
JP2024198093A Pending JP2025024083A (ja) 2022-09-29 2024-11-13 滅菌処理したヘテロシクリデンアセトアミド誘導体含有懸濁液

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024198093A Pending JP2025024083A (ja) 2022-09-29 2024-11-13 滅菌処理したヘテロシクリデンアセトアミド誘導体含有懸濁液

Country Status (7)

Country Link
EP (1) EP4595959A1 (https=)
JP (2) JP7589393B2 (https=)
KR (1) KR20250065723A (https=)
CN (1) CN119997937A (https=)
AU (1) AU2023352012A1 (https=)
MX (1) MX2025003326A (https=)
WO (1) WO2024071348A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025206172A1 (ja) * 2024-03-28 2025-10-02 千寿製薬株式会社 電子線滅菌処理したヘテロシクリデンアセトアミド誘導体含有組成物

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018203648A (ja) 2017-05-31 2018-12-27 持田製薬株式会社 ヘテロシクリデンアセトアミド誘導体の結晶
WO2021066144A1 (ja) 2019-10-04 2021-04-08 千寿製薬株式会社 ヘテロシクリデンアセトアミド誘導体含有医薬

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ565080A (en) 2005-07-22 2011-03-31 Mochida Pharm Co Ltd Novel heterocyclidene acetamide derivative
CN112409191A (zh) 2019-08-23 2021-02-26 持田制药株式会社 光学活性的氨基醇的制备方法
PL4019485T3 (pl) 2019-08-23 2024-10-21 Mochida Pharmaceutical Co., Ltd. Sposób wytwarzania pochodnych heterocyklidenoacetamidu
WO2021039023A1 (ja) 2019-08-23 2021-03-04 持田製薬株式会社 ヘテロシクリデンアセトアミド誘導体の製造方法
JP7663009B2 (ja) 2021-03-31 2025-04-16 ニデックパワートレインシステムズ株式会社 回転電機、およびポンプ

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018203648A (ja) 2017-05-31 2018-12-27 持田製薬株式会社 ヘテロシクリデンアセトアミド誘導体の結晶
WO2021066144A1 (ja) 2019-10-04 2021-04-08 千寿製薬株式会社 ヘテロシクリデンアセトアミド誘導体含有医薬

Also Published As

Publication number Publication date
MX2025003326A (es) 2025-05-02
AU2023352012A1 (en) 2025-04-03
KR20250065723A (ko) 2025-05-13
JPWO2024071348A1 (https=) 2024-04-04
JP2025024083A (ja) 2025-02-19
CN119997937A (zh) 2025-05-13
WO2024071348A1 (ja) 2024-04-04
EP4595959A1 (en) 2025-08-06

Similar Documents

Publication Publication Date Title
JP7312523B2 (ja) フルベストラント配合物およびその使用方法
US12527740B2 (en) Suspension containing heterocyclidene acetamide derivative
JP7026609B2 (ja) 微細粒子含有組成物およびその製法
JP7589393B2 (ja) 滅菌処理したヘテロシクリデンアセトアミド誘導体含有懸濁液
WO2018215638A1 (en) Pharmaceutical compositions comprising azithromycin
KR102912349B1 (ko) 눈의 상황을 치료하기 위한 제제
EA009843B1 (ru) Содержащая циклесонид стерильная водная суспензия
JP2004514692A (ja) トラマドールとジクロフェナクの塩の懸濁液を含有する非経口投与可能な剤形
US10463674B2 (en) Process for manufacturing sterile ophthalmic pharmaceutical suspensions
JP7589394B2 (ja) ヘテロシクリデンアセトアミド誘導体を含む配合剤
CA3268119A1 (en) Sterilized heterocyclidene-acetamide-derivative-containing suspension
WO2025206172A1 (ja) 電子線滅菌処理したヘテロシクリデンアセトアミド誘導体含有組成物
KR20220144359A (ko) 점안제로부터의 보존제 제거
El Hashemy et al. Novel In Situ Gel for Molnupiravir-Loaded Niosomes: Design, In Vitro Characterization and In Vivo Evaluation‎
WO2021199076A1 (en) Injectable aripiprazole formulation
WO2022195382A1 (en) A stable ophthalmic nanosupension of brinzolamide
WO2025172499A1 (en) Quetiapine liquid formulations
TW202404603A (zh) 包含ｃｆｔｒ活化劑的組成物
HK40049829B (zh) 阿立哌唑前体药物组合物

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240409

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240409

A871 Explanation of circumstances concerning accelerated examination

Free format text: JAPANESE INTERMEDIATE CODE: A871

Effective date: 20240409

AA64 Notification of invalidation of claim of internal priority (with term)

Free format text: JAPANESE INTERMEDIATE CODE: A241764

Effective date: 20240423

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20240604

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240802

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20241015

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20241113

R150 Certificate of patent or registration of utility model

Ref document number: 7589393

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150